154 related articles for article (PubMed ID: 12457286)
1. IL-10 gene therapy prevents TNBS-induced colitis.
Lindsay J; Van Montfrans C; Brennan F; Van Deventer S; Drillenburg P; Hodgson H; Te Velde A; Sol Rodriguez Pena M
Gene Ther; 2002 Dec; 9(24):1715-21. PubMed ID: 12457286
[TBL] [Abstract][Full Text] [Related]
2. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis.
Lindsay JO; Ciesielski CJ; Scheinin T; Brennan FM; Hodgson HJ
Gut; 2003 Mar; 52(3):363-9. PubMed ID: 12584217
[TBL] [Abstract][Full Text] [Related]
3. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis.
Lindsay JO; Ciesielski CJ; Scheinin T; Brennan FM; Hodgson HJ
Gut; 2003 Jul; 52(7):981-7. PubMed ID: 12801955
[TBL] [Abstract][Full Text] [Related]
4. IL-10 gene therapy is therapeutic for dextran sodium sulfate-induced murine colitis.
Lindsay JO; Sandison A; Cohen P; Brennan FM; Hodgson HJ
Dig Dis Sci; 2004 Aug; 49(7-8):1327-34. PubMed ID: 15387364
[TBL] [Abstract][Full Text] [Related]
5. Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model.
Van Montfrans C; Rodriguez Pena MS; Pronk I; Ten Kate FJ; Te Velde AA; Van Deventer SJ
Gastroenterology; 2002 Dec; 123(6):1865-76. PubMed ID: 12454844
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
[TBL] [Abstract][Full Text] [Related]
7. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
9. The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10.
Lindsay JO; Ciesielski CJ; Scheinin T; Hodgson HJ; Brennan FM
J Immunol; 2001 Jun; 166(12):7625-33. PubMed ID: 11390520
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
[TBL] [Abstract][Full Text] [Related]
11. RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease.
Bourreille A; Doubremelle M; de la Blétière DR; Segain JP; Toquet C; Buelow R; Galmiche JP
Scand J Gastroenterol; 2003 May; 38(5):526-32. PubMed ID: 12795464
[TBL] [Abstract][Full Text] [Related]
12. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
Duchmann R; Schmitt E; Knolle P; Meyer zum Büschenfelde KH; Neurath M
Eur J Immunol; 1996 Apr; 26(4):934-8. PubMed ID: 8625991
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
[TBL] [Abstract][Full Text] [Related]
14. [Suppression of Schistosoma japonicum eggs on TNBS-induced colitis in mice].
Mo HM; Liu WQ; Lei JH; Cheng YL; Wang CZ; Li YL
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Oct; 25(5):381-4. PubMed ID: 18441989
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
16. Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of inflammatory bowel disease.
Lee J; Lee EN; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Lee KW; Kwon GY; Joh JW; Kim SJ
Immunol Lett; 2005 Nov; 101(2):210-6. PubMed ID: 16026855
[TBL] [Abstract][Full Text] [Related]
17. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
18. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.
Shlomai A; Trop S; Gotsman I; Jurim O; Diment J; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pathol; 2001 Nov; 195(4):498-507. PubMed ID: 11745683
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of mouse acute colitis by naked hepatocyte growth factor gene transfer into the liver.
Hanawa T; Suzuki K; Kawauchi Y; Takamura M; Yoneyama H; Han GD; Kawachi H; Shimizu F; Asakura H; Miyazaki J; Maruyama H; Aoyagi Y
J Gene Med; 2006 May; 8(5):623-35. PubMed ID: 16479533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
